FDA Issues Class 1 Recall of Medtronic Guidewires

- by

Minneapolis, MN: Medtronic, Inc. (NYSE: MDT) announced today that the US Food and Drug Administration (FDA) has classified the company's recently initiated voluntary field action related to certain guidewires as a Class I recall.

The FDA action is based on an internal investigation following a limited number of complaints and patient injury. Medtronic began notifying hospitals and distributors worldwide the week of October 21 that some models of its guidewires from recent lots have the potential for the coating on their surface to delaminate and detach. The notification requested that all potentially affected units be quarantined immediately and returned to the company as soon as possible for credit and replacement.

The FDA defines a Class I recall as a situation in which there is a reasonable probability that use of, or exposure to, a violative product will cause serious adverse health consequences or death.

The guidewires covered by this recall are designed to facilitate percutaneous coronary interventions or the placement of left ventricular leads for cardiac rhythm devices. They include specific lots from the following eight product lines that were manufactured after mid-April 2013:

Cougar nitinol workhorse guidewire

Cougar steerable guidewire

Zinger stainless steel workhorse guidewire

Zinger steerable guidewire

Thunder extra-support guidewire

Thunder steerable guidewire

ProVia crossing guidewire

Attain Hybrid guide wire

Legal Help

If you or a loved one has suffered similar damages or injuries, please fill in our form on the right and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.

Add Your Comment on This Issue

Please read our comment guidelines before posting.

Note: Your name will be published with your comment.

Your email will only be used if a response is needed.

Request Legal Help